Patients with hypertension and the AC genotype may have a decreased response to atenolol or metoprolol, as measured by change in diastolic blood pressure, as compared to patients with the AA genotype, but an increased response as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's response to atenolol or metoprolol.